Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents - A single blind randomized trial

Reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) vaccine, Boostrix™, is indicated for booster vaccination of children, adolescents and adults. The original prefilled disposable dTpa syringe presentation was recently replaced by another prefilled-syringe presentation with latex-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavia-Ruz, Noris, Abarca, Katia, Lepetic, Alejandro, Cervantes-Apolinar, Maria Yolanda, Hardt, Karin, Jayadeva, Girish, Kuriyakose, Sherine, Han, Htay Htay, de la O, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514261/
https://www.ncbi.nlm.nih.gov/pubmed/26075317
http://dx.doi.org/10.1080/21645515.2015.1041697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514261/
https://www.ncbi.nlm.nih.gov/pubmed/26075317
http://dx.doi.org/10.1080/21645515.2015.1041697

Ejemplares similares